All Articles

Charlotte Tilbury's extended partnership with the Dallas Cowboys Cheerleaders reveals a strategic shift in how prestige cosmetics conquer American e-commerce.

A new survey reveals 63% of shoppers will let AI pick brands for a 20% discount, but strict fears over fraud and liability halt autonomous checkout.

As 'pinkwashing' scrutiny grows, G-SHOCK’s flat-fee philanthropy and strategic use of the 'CasiOak' silhouette offer a blueprint for authentic corporate giving.

South Korea's Yuyu Pharma is pivoting from human medicine to feline supplements, leveraging Amazon's AI tools to conquer the U.S. pet wellness market.

Trio Petroleum expands its Canadian footprint with a strategic Lloydminster acquisition, trading equity cash for heavy-oil production and hidden liabilities.

As capital costs soar, gold developers are trading equity dilution for physical metal debt. We examine the hidden risks of this rapid commercialization strategy.

As consumer demand for alternative sweeteners like allulose surges, DuPont’s new digital advisor uses empirical data to lock in early-stage R&D customers.

Canopy's latest API launch and Model Context Protocol integration signal a massive shift from monolithic software to open, AI-ready accounting ecosystems.

Ørsted’s 200 MW Blackwater Solar project isn’t just about green energy. It’s a masterclass in navigating industrial demand, IRA incentives, and local politics.

By embedding stablecoins into standard payment APIs, Kora’s new One Rail bypasses exorbitant fees and dollar shortages for African cross-border merchants.

Nutrafol is expanding beyond supplements with a $54 strand serum. Can its plant-based formula compete with Olaplex and K18 in the hair longevity space?

EY’s new alliance with AI startup Aaru replaces months of traditional market research with synthetic human simulations, reshaping high-stakes corporate strategy.

AI fashion platform Daydream integrates deeply with Apple's iOS 27, proving the future of shopping isn't another app—it's an ambient, frictionless service.

NuCana's new European patent for its cancer drug NUC-7738 strengthens its global IP moat, backing its clinical push against PD-1 resistant melanoma into 2029.

A new partnership pairs traceable AI with validated psychographic segmentation, aiming to make synthetic consumer research a reliable enterprise asset.

In a challenging private equity market, Stride Consumer Partners closed its oversubscribed $550 million second fund in just four months to back passion brands.

As Visible Gold Mines consolidates its Quebec gold assets, the addition of a seasoned exploration executive signals a pivot toward aggressive resource development.

As AI and streaming dominate our screens, a new venture is betting that tangible movie artifacts are the key to unlocking real-world human connection.

As hospitals rush to adopt AI, ungoverned non-human identities are exploiting decades of legacy IT debt, putting patient data at unprecedented risk.

Latvia's recent US trade mission secured strategic partnerships with defense and biotech giants, positioning the Baltic nation as a high-tech proving ground.